Edition:
India

OHR Pharmaceutical Inc (OHRP.OQ)

OHRP.OQ on NASDAQ Stock Exchange Capital Market

1.52USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
136,348
52-wk High
$1.90
52-wk Low
$0.57

Chart for

About

Ohr Pharmaceutical, Inc. is a pharmaceutical company focused on the development of therapeutics and delivery technologies for the treatment of ocular disease. The Company's development pipeline consists of several programs and indications at various stages of development. Its product pipeline includes Squalamine Lactate... (more)

Overall

Beta: 0.36
Market Cap(Mil.): $39.03
Shares Outstanding(Mil.): 56.21
Dividend: --
Yield (%): --

Financials

BRIEF-Ohr Pharmaceutical files for mixed shelf of up to $250 mln

* Files for mixed shelf of up to $250 million - SEC filing‍​ Source text: (http://bit.ly/2x8VRBB) Further company coverage:

16 Sep 2017

BRIEF-OHR Pharmaceutical Q3 loss per share $0.07

* OHR Pharmaceutical announces fiscal third quarter 2017 earnings

09 Aug 2017

Competitors

Earnings vs. Estimates